Aurora Cannabis Inc
TSX:ACB

Watchlist Manager
Aurora Cannabis Inc Logo
Aurora Cannabis Inc
TSX:ACB
Watchlist
Price: 6.05 CAD 0.5% Market Closed
Market Cap: 332m CAD
Have any thoughts about
Aurora Cannabis Inc?
Write Note

Aurora Cannabis Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aurora Cannabis Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Aurora Cannabis Inc
TSX:ACB
Research & Development
-CA$3.5m
CAGR 3-Years
35%
CAGR 5-Years
28%
CAGR 10-Years
-61%
Bausch Health Companies Inc
TSX:BHC
Research & Development
-$605m
CAGR 3-Years
-9%
CAGR 5-Years
-5%
CAGR 10-Years
-9%
Sundial Growers Inc
NASDAQ:SNDL
Research & Development
-CA$324k
CAGR 3-Years
13%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Research & Development
-$4.7m
CAGR 3-Years
41%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Research & Development
-$53.7m
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
-120%
C
Curaleaf Holdings Inc
CNSX:CURA
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Aurora Cannabis Inc
Glance View

Market Cap
331.9m CAD
Industry
Pharmaceuticals

Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. The firm's principal business lines are focused on the production, distribution and sale of cannabis and cannabis related products in Canada and internationally. The firm's portfolio of brands includes Aurora, Aurora Drift, San Rafael '71, Daily Special, MedReleaf, CanniMed, Whistler, Reliva and KG7 CBD. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia; and Odense, Denmark. The firm is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets. The company produces approximately 150,000 kilograms (kg) of cannabis biomass annually. Its subsidiaries include 1769474 Alberta Ltd., 2105657 Alberta Inc., Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Aurora Nordic Cannabis A/S, and Reliva, LLC, among others.

ACB Intrinsic Value
8.7 CAD
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Aurora Cannabis Inc's Research & Development?
Research & Development
-3.5m CAD

Based on the financial report for Sep 30, 2024, Aurora Cannabis Inc's Research & Development amounts to -3.5m CAD.

What is Aurora Cannabis Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-61%

Over the last year, the Research & Development growth was 35%. The average annual Research & Development growth rates for Aurora Cannabis Inc have been 35% over the past three years , 28% over the past five years , and -61% over the past ten years .

Back to Top